Mr. Ballinger Kevin

Biography

Kevin Ballinger is Executive Vice President and Global President, Interventional Cardiology for Boston Scientific and a member of its Executive Committee. In his current role, Ballinger is responsible for developing and bringing to market innovative solutions that diagnose and treat coronary artery disease and structural heart disorders. Ballinger has more than 20 years of interventional cardiology experience. Prior his current role, he served as President of the Boston Scientific Interventional Cardiology business unit and held a variety of engineering and general management positions, including overseeing the development of the company’s first drug-eluting stents. Ballinger earned a B.S. in Mechanical Engineering from Michigan Technological University and an M.B.A. from the University of Minnesota.

Research Interest

Kevin Ballinger expertise in interventional cardiology